Luminescence as a Detection Strategy

Limitations of Fluorescence Based Detection

Fluorescence has played a central role in the development of protein-based antibody sensors and remains a widely used detection strategy. However, fluorescence-based assays require external illumination to excite fluorophores, which inevitably introduces background signals caused by autofluorescence and light scattering from biological samples. These interference effects limit achievable sensitivity and constrain the lower detection limit to the minimum sensor concentration that can be reliably distinguished from noise.

Advantages of Luminescence

Luminescence offers a compelling alternative to fluorescence-based detection. Because light is generated chemically or enzymatically, without the need for external excitation, background interference is minimal, and extremely low signal levels can be detected with high accuracy.

Luminescent detection provides a wide dynamic range and exceptional sensitivity, making it particularly well suited for applications requiring low limits of detection. The ability to amplify signals through enzymatic reactions further enhances performance, establishing luminescence as one of the most sensitive detection strategies currently available.

Forms of Luminescence

Several forms of luminescence are used in bioanalytical assays:

  1. Photoluminescence (fluorescence): excitation induced by external excitation
  2. Chemiluminescence: light produced through a chemical reaction
  3. Bioluminescence: light generated enzymatically by luciferase proteins

Bioluminescence

Enzymatic Light Generation

Bioluminescence is based on the enzymatic conversion of a substrate into light by a luciferase protein. Because light is generated internally by the reaction itself, no external illumination is required, eliminating the excitation-related background that limits fluorescence-based approaches and enabling highly sensitive detection.

Historically, luciferases were not widely adopted in diagnostic applications due to constraints in brightness, stability, and robustness under demanding assay conditions. Recent advances in protein engineering have addressed many of these limitations, giving rise to a new generation of luciferase-based sensors with significantly improved photon output and operational stability.

These engineered luciferases are well suited for integration into homogeneous immunoassays, enabling reliable detection of low-abundance biomarkers in complex biological matrices such as blood plasma or serum. Our assays make use of NanoLuc®, an engineered luciferase that meets the performance requirements of our platform in terms of brightness and stability.

 

NanoLuc® is a registered trademark of Promega Corporation.